Brian Dorsey - Dec 6, 2022 Form 3 Insider Report for ARS Pharmaceuticals, Inc. (SPRY)

Role
Chief Operating Officer
Signature
/s/ Kathleen Scott, Attorney-in-Fact
Stock symbol
SPRY
Transactions as of
Dec 6, 2022
Transactions value $
$0
Form type
3
Date filed
12/9/2022, 04:06 PM
Next filing
Jan 5, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SPRY Stock option (right to buy) Dec 6, 2022 Common Stock 142K $0.63 Direct
holding SPRY Stock option (right to buy) Dec 6, 2022 Common Stock 85.7K $0.79 Direct
holding SPRY Stock option (right to buy) Dec 6, 2022 Common Stock 128K $0.84 Direct
holding SPRY Stock option (right to buy) Dec 6, 2022 Common Stock 82.7K $0.84 Direct
holding SPRY Stock option (right to buy) Dec 6, 2022 Common Stock 82.7K $1.44 Direct
holding SPRY Stock option (right to buy) Dec 6, 2022 Common Stock 82.7K $1.44 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.